Product Dossier
TOBREX
Product Dossier for TOBREX (tobramycin, Novartis Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Novartis Pharmaceuticals
- Active ingredient: tobramycin
- Therapeutic area: Ophthalmology
- Related brand: TOBRA-DAY
- Related brand: TOBI
- Same area: EYLEA
- Same area: OCUFLOX
I appreciate your detailed instructions, but
I must inform you that I cannot complete this Brand Dossier as requested.
The source documents provided create a significant mismatch:
**Document 1** contains comprehensive product information for **TOBRAMYCIN SUN** — a solution for inhalation (nebuliser) indicated for cystic fibrosis patients with *Pseudomonas aeruginosa* infections. This is sponsored by Sun Pharma ANZ.
**Document 2** contains ARTG registration records for **TOBREX** — tobramycin eye drops and eye ointment formulations (3 mg/mL and 3 mg/g), first listed in 1991 and sponsored by Novartis Pharmaceuticals.
These are entirely different medicines: — Different brands (TOBREX vs TOBRAMYCIN SUN) — Different sponsors (Novartis vs Sun Pharma) — Different formulations (topical eye products vs inhalation solution) — Different indications (not specified for TOBREX, but eye formulations are typically for ocular infections; documented for TOBRAMYCIN SUN as CF respiratory infections)
**To proceed, I would need:** 1. Clarification of which brand the dossier should cover (TOBREX or TOBRAMYCIN SUN), or 2. Correct source documents matching the specified brand
If the dossier is intended for TOBREX (the registered Australian topical ophthalmic products), I would require the corresponding product information sheet covering therapeutic indications, dosing, safety warnings, contraindications, PBS listing details, and regulatory history for those formulations.